This document is a draft ICH guideline on residual solvents, including a revision of the Permissible Daily Exposure (PDE) for Tetrahydrofuran (THF).
This ICH harmonised guideline addresses residual solvents in drug substances, excipients, and drug products. It recommends acceptable amounts for patient safety and classifies solvents into groups to be avoided, limited, or used where practical.
The document also describes scope, general principles, reporting levels, and testing considerations, including when drug-product testing may not be needed based on cumulative calculations from ingredient levels.
It recommends acceptable amounts for residual solvents in pharmaceuticals for the safety of the patient.
No, it does not address solvents deliberately used as excipients or solvates.
When a cumulative calculation from ingredient levels results in a level equal to or below the recommended level.
Class 1 solvents known to cause unacceptable toxicities should be avoided unless their use can be strongly justified.